IFNA1 and systemic lupus erythematosus: Type I IFN is considered to be critical for systemic lupus erythematosus (SLE) disease pathogenesis and the increased expression of IFN-regulated genes (termed the IFN signature), and the levels of type I IFN correlate with the production of autoantibodies and disease activity.